2026 NPPES data Internal Medicine Physician NPI 1518279140 M.D.
Verify on CMS →

PEDRO GONZALEZ ZAYAS, M.D.

Internal Medicine Physician in ELMIRA, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 160 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$47.35
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

PEDRO GONZALEZ ZAYAS, M.D. filed 1,980 Medicare Part D claims in 2023 as a Internal Medicine Physician in ELMIRA, New York, prescribing 84% generic.

2K
Part D claims, 2023
84%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PEDRO GONZALEZ ZAYAS, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,980 Top 16% higher than 84% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). This entry sits in this band. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

PEDRO GONZALEZ ZAYAS, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about PEDRO GONZALEZ ZAYAS, M.D.?

Quality data not reported

NPI registry status

Active

Issued 07/12/2010

NPI 1518279140

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

1,980 27% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

Specialty distribution in New York

How Internal Medicine Physician compares to other specialties among New York providers

New York providers

Internal Medicine Physician share within New York

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Internal Medicine Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Internal Medicine Physician ABMS/AOA estimate

Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Internal Medicine Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PEDRO GONZALEZ ZAYAS, M.D. appears in the CMS NPPES registry as a Internal Medicine Physician provider holding M.D. credentials at 200 MADISON AVE, ELMIRA, NY, 14901, with a listed phone of (607) 734-1581. NPI 1518279140 was issued on 07/12/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GONZALEZ ZAYAS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,980 prescription claims written by this provider, covering 160 Medicare beneficiaries and totaling roughly $271K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 2.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

200 MADISON AVE
ELMIRA, NY 14901

Provider Details

NPI 1518279140
Specialty Internal Medicine Physician
Credentials M.D.
Gender Male
NPI Issued 07/12/2010

Hospital and facility affiliations

Facilities where PEDRO GONZALEZ ZAYAS, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

FINGER LAKES COMMUNITY HEALTH
PENN YAN, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PEDRO GONZALEZ ZAYAS, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$47

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to PEDRO GONZALEZ ZAYAS, M.D.. To verify PEDRO GONZALEZ ZAYAS, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

PEDRO GONZALEZ ZAYAS, M.D. — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 1,980 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,980
Total Claims
$271K
Total Drug Cost
160
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,357
Total Day Supply
96,181
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$218K
Generic Drug Cost
$52K
Opioid Claims
44 (2.2% rate)
Antibiotic Claims
68

Patient Demographics

Average Patient Age
64.0 years
Avg HCC Risk Score
1.39
Gender Split
49% female / 51% male
Age Distribution
<65: 61, 65-74: 66, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What PEDRO GONZALEZ ZAYAS, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
110
Rosuvastatin Calcium
100
Lisinopril
88
Albuterol Sulfate Hfa
Albuterol Sulfate
70
Atorvastatin Calcium
68
Pantoprazole Sodium
63
Buprenorphine-Naloxone
Buprenorphine Hcl/Naloxone Hcl
51
Omeprazole
48
Gabapentin
42
Metformin Hcl
34

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How PEDRO GONZALEZ ZAYAS, M.D. fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

PEDRO GONZALEZ ZAYAS, M.D.'s 1,980 claims are below the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as GONZALEZ ZAYAS.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PEDRO GONZALEZ ZAYAS, M.D.'s specialty?
PEDRO GONZALEZ ZAYAS, M.D. specializes in Internal Medicine Physician and practices in ELMIRA, New York. Credentials: M.D..
How much does PEDRO GONZALEZ ZAYAS, M.D. prescribe under Medicare Part D?
In 2023, PEDRO GONZALEZ ZAYAS, M.D. wrote 1,980 Medicare Part D claims totaling $271K in drug costs for 160 beneficiaries.
Where is PEDRO GONZALEZ ZAYAS, M.D. located?
PEDRO GONZALEZ ZAYAS, M.D. is located at 200 MADISON AVE, ELMIRA, NY, 14901. Phone: (607) 734-1581.
What is PEDRO GONZALEZ ZAYAS, M.D.'s NPI number?
PEDRO GONZALEZ ZAYAS, M.D.'s National Provider Identifier (NPI) is 1518279140, issued on 07/12/2010.
Does PEDRO GONZALEZ ZAYAS, M.D. prescribe more brand-name or generic drugs?
PEDRO GONZALEZ ZAYAS, M.D.'s prescribing is 16% brand-name and 84% generic drugs by claim count, with $218K in brand drug costs.
Does PEDRO GONZALEZ ZAYAS, M.D. prescribe opioids?
Yes, PEDRO GONZALEZ ZAYAS, M.D. had 44 opioid claims in 2023 with an opioid prescribing rate of 2.2%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does PEDRO GONZALEZ ZAYAS, M.D. prescribe most often?
Based on 2023 Medicare Part D data, PEDRO GONZALEZ ZAYAS, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Rosuvastatin Calcium, Lisinopril. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PEDRO GONZALEZ ZAYAS, M.D. accept Medicare?
PEDRO GONZALEZ ZAYAS, M.D. appears in CMS Medicare data with 1,980 Part D claims and 160 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PEDRO GONZALEZ ZAYAS, M.D.'s credentials?
PEDRO GONZALEZ ZAYAS, M.D.'s NPI is 1518279140 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology